Defective Drugs:
Serious Allergic Reactions Linked to Heparin
Heparin Recall
Manufactured by Baxter International, Heparin is a quick acting blood thinner that used in dialysis and surgery. Heparin prevents blood clots in the veins, arteries, and lungs.
In Jan. 2008, several lots of Heparin were recalled after approximately 100 reports of serious allergic reactions. Baxter announced it would suspend the manufacturer of Heparin until further research had been done. In Feb. 2008, The FDA advised doctors to discontinue use of Heparin as 350 reports of adverse side effects were reported. The FDA also received notice of four deaths linked to Heparin. In cases where side effects were reported, Heparin was administered in high doses over a short period of time.
Eventually, in late Feb. 2008, the FDA recalled all Heparin products as they had been linked to 400 serious reactions and up to 21 deaths. These serious Heparin side effects including anaphylactic shock, tachycardia, decreased blood pressure, loss of consciousness, dyspnea, pharyngeal edema and heart palpitations.